1.
Bioorg Med Chem Lett
; 16(4): 934-7, 2006 Feb 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16297619
RESUMO
A novel series of 2-anilino-3-phenylsulfonyl-6-methylpyridines was synthesized and evaluated as corticotropin-releasing factor receptor ligands. Structure-activity relationship studies focused primarily on optimization of the 3-phenylsulfonyl group. Compounds within this series were identified which showed potent binding affinity for the CRF1 receptor. Selected compounds were examined in a rat pharmacokinetic study and were found to have oral bioavailabilities ranging from 16 to 35%.